FDA Accepts for Review Biohaven’s New Drug Application (NDA) Filing of Intranasal Zavegepant for the Acute Treatment of Migraine Read more
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand Read more
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers Read more
Novartis Cosentyx (secukinumab) receives positive CHMP opinion for expanded use in childhood arthritic conditions Read more
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza for the Treatment of AADC Deficiency Read more
Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines Read more
AbbVie Submits New Drug Application to FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson’s Disease Read more